What RFK Jr. can do as Secretary of Health and Human Services

 by Alex Berenson

If Robert F. Kennedy Jr. could press even half of these through, he would be a success as Secretary of Health and Human Services, whatever else happens.

(This is a non-exhaustive list; feel free to add your own suggestions.)

1. Find a constitutionally viable way to limit prescription drug advertising. A full ban is impossible, but tighter restrictions can pass First Amendment muster if they’re carefully crafted.

2. Declassify and release all documents the National Institutes of Health possesses related to the lab-leak theory of Sars-Cov-2, focusing on those on the relationship between Dr. Ralph Baric and Dr. Anthony Fauci.

3. Update the 2006 pandemic plan, emphasizing the lessons learned from the Covid crisis and the need to keep schools open and society functioning normally.

4. Push repeal of the 1986 law that gives vaccine manufacturers essentially total immunity for vaccine-caused injuries.

5. Tighten the restrictions on physician-owned and -financed outpatient medical centers; American physicians are extremely well-paid and should not be in the business of profiting from the procedures they prescribe.

6. Limit compensation of executives at non-profit hospitals and chains, by, for example, saying that no non-profit executive can receive more than $1 million annually in total compensation as a condition of Medicare participation. (Make it $2 million if you must.)

7. Fund a full investigation into the health impacts of the Covid mRNA vaccines, including known side effects like myocarditis as well as potentially serious changes like the IgG4 class switch.

8. Declassify and release all documents related to Operation Warp Speed, focusing on those discussing whether its members ever considered forcing vaccine companies to participate in a head-to-head trial.

9. Encourage generic “biosimilars” for very, very expensive prescription biologics like Humira to make them as common as generic small-molecule competitors to drugs like Lipitor.

10. End the revolving door between the agencies and the medical-industrial complex and Big Pharma in particular by instituting a rule that no senior regulator may take a job or board membership at a healthcare company for at least three years, and no commissioner or C-suite member for at least a decade. Call it the Gottlieb rule, in honor of Dr. Scott Gottlieb, former Food and Drug Administration commissioner, current Pfizer board member and defendant in Berenson v Biden.

https://alexberenson.substack.com/p/what-rfk-jr-can-do-as-secretary-of